MeSH term
Frequency | Condition_Probility | Bipolar Disorder/*genetics | 2 | 1.0 |
Chromosomes, Human, Pair 21/*genetics | 3 | 3.0 |
Genetic Markers | 6 | 0.0 |
Humans | 23 | 0.0 |
*Linkage (Genetics) | 6 | 0.0 |
Pedigree | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Animals | 7 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
Comparative Study | 5 | 0.0 |
Female | 8 | 0.0 |
Mice | 4 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Polyendocrinopathies, Autoimmune/*genetics | 2 | 13.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Alleles | 2 | 0.0 |
Genotype | 4 | 0.0 |
Lod Score | 2 | 0.0 |
Male | 7 | 0.0 |
Chromosome Mapping/*methods | 2 | 1.0 |
*Chromosomes, Human, Pair 21 | 10 | 6.0 |
Cloning, Molecular | 3 | 0.0 |
Cosmids | 3 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Phenotype | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
Exons | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Adult | 3 | 0.0 |
Base Sequence | 7 | 0.0 |
Child | 3 | 0.0 |
Chromosomes, Human, Pair 21 | 2 | 1.0 |
DNA Primers | 2 | 0.0 |
Epilepsies, Myoclonic/*genetics | 2 | 9.0 |
Brain/enzymology | 2 | 1.0 |
Finland | 2 | 0.0 |
Liver/enzymology | 2 | 0.0 |
Phosphofructokinase-1/*genetics/metabolism | 2 | 100.0 |
Hamsters | 2 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
*Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Liver/*enzymology | 2 | 0.0 |
Phosphofructokinase-1/*genetics | 4 | 25.0 |